Skip to content

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Adaptation of an HPV Education Resource to Promote HPV Vaccination Among Latino Young Men Who Have Sex With Men in Puerto Rico and Florida -- Proyecto Hombres Previniendo el VPH (Proyecto HPV)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04974619
Enrollment
155
Registered
2021-07-23
Start date
2021-07-23
Completion date
2022-08-30
Last updated
2024-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV, HPV Vaccine

Brief summary

The purpose of the study is to assess Human Papillomavirus (HPV) and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences for learning more about HPV and HPV vaccination and to receive feedback on and adapt HPV educational materials for Young Latino Men who have Sex with Men (YLMSM).

Detailed description

To assess HPV and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences among 260 Spanish-speaking YLMSM ages 18-26 in Florida and Puerto Rico. To conduct 20 in-depth interviews with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation. To culturally adapt an existing Cancer 101 educational resource in English and Spanish for YLMSM ages 18-26 and to conduct focus groups or individual interviews with 24 YLMSM in PR (n=12) and FL (n=12) to gain feedback on the acceptability, accessibility, content, delivery preferences, and aesthetics of the theoretically informed, HPV educational intervention targeted for English and/or Spanish-speaking YLMSM.

Interventions

BEHAVIORALOnline survey

Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.

BEHAVIORALFocus groups or Individual Interviews

Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.

BEHAVIORALInterviews

In-depth interviews (n=20) will be conducted with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
H. Lee Moffitt Cancer Center and Research Institute
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Aim 1 & 3: * Men who have had sex with a man and/or are attracted to men * Hispanic/Latino ethnicity * Able to read, write and understand Spanish (for Aim 1) and Spanish or English (for Aim 3) * Aged 18-26 years * Primary residence in either Puerto Rico or Florida * Has access to the internet (Aim 1 only) Additional criteria for Aim 3: * Has regular access to a working telephone or be able to attend an in-person focus group (modifications related to COVID-19 situation will allow virtual modality to complete the focus groups or individual interviews). * Able to read, write and understand Spanish or English Inclusion Criteria for Aim 2: * Individuals with a current or prior role (within last twelve months) in a community-based organization, private or public healthcare clinic, health department, college/university organization, or interest group that provides services to sexual minorities in FL or PR as a healthcare provider, staff member, group member, or in a leadership role * Age 21 or older * Able to understand, read and speak either Spanish or English * Access to a working telephone or computer

Exclusion criteria

for Aim 1 & 3: * Self identifies as either transman or transwoman * aged \<18 years or \>27 years * Individuals who contact the research team about interest in participating on Aims 1 or 3 (when recruitment cap has been completed for that aim) can be directed to Aims 1 or 3 for possible recruitment. Individuals can participate in more than 1 aim, but not more than one time in a single aim.

Design outcomes

Primary

MeasureTime frameDescription
Part 1: HPV Vaccine Knowledge (Aim 1)Day 1A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge.
Part 1: HPV Vaccine Awareness (Aim 1)Day 1A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness
Part 1: HPV Vaccine Attitude (Aim 1)Day 1A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40.
Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)Day 1Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy.
Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)Day 1Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know.
Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)Day 1Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions.
Part 1: HPV Vaccine Behaviors 1 (Aim 1)Day 1Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know.
Part 1: HPV Vaccine Behaviors 2 (Aim 1)Day 1Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know.
Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)Day 1A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Who would you like to receive information from?. Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied.
Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)Day 1Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Best method for delivering education?. 1 being the best method and 8 being the worst method.
Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)Day 1An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, What age would it be most helpful to for a person to receive educational information?
Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2)Day 1Number of participants who consented and participated in individual interviews.
Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3)Day 1Number of Participants who completed either an individual interview or participated in a focus group.

Countries

Puerto Rico, United States

Participant flow

Participants by arm

ArmCount
Aim 1 Only: Online Survey Group
Spanish speaking young Latino men who have sex with men (YLMSM), ages 18-26 (in Florida and Puerto Rico) will be asked to complete a Qualtrics survey. Online survey: Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
117
Aim 2 Only: Interview Group
Individual interviews will be conducted with key healthcare stakeholders (i.e.,healthcare clinical leadership, providers and staff, community-based organization staff) Interviews: In-depth interviews will be conducted with key stakeholders eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.
21
Aim 3 Only: Focus Groups or Interview Group
Each site will conduct focus groups or individual interviews with English or Spanish speaking young Latino men who have sex with men (YLMSM). Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
17
Total155

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up001
Overall StudyProtocol Violation010
Overall StudyWithdrawal by Subject001

Baseline characteristics

CharacteristicAim 1 Only: Online Survey GroupAim 2 Only: Interview GroupAim 3 Only: Focus Groups or Interview GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
117 Participants21 Participants17 Participants155 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
117 Participants11 Participants17 Participants145 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants6 Participants0 Participants6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants4 Participants0 Participants4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants0 Participants3 Participants
Race (NIH/OMB)
Black or African American
26 Participants2 Participants0 Participants28 Participants
Race (NIH/OMB)
More than one race
10 Participants0 Participants0 Participants10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants0 Participants0 Participants2 Participants
Race (NIH/OMB)
Unknown or Not Reported
25 Participants10 Participants15 Participants50 Participants
Race (NIH/OMB)
White
52 Participants7 Participants2 Participants61 Participants
Region of Enrollment
Puerto Rico
96 participants11 participants13 participants120 participants
Region of Enrollment
United States
21 participants10 participants4 participants35 participants
Sex/Gender, Customized
Female
0 Participants6 Participants0 Participants6 Participants
Sex/Gender, Customized
Male
117 Participants12 Participants17 Participants146 Participants
Sex/Gender, Customized
Unknown
0 Participants3 Participants0 Participants3 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 00 / 00 / 0
other
Total, other adverse events
0 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 0

Outcome results

Primary

Part 1: HPV Vaccine Attitude (Aim 1)

A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40.

Time frame: Day 1

ArmMeasureValue (MEAN)Dispersion
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Attitude (Aim 1)27.38 score on a scaleStandard Deviation 4.36
Primary

Part 1: HPV Vaccine Awareness (Aim 1)

A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness

Time frame: Day 1

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Awareness (Aim 1)Ever Heard of HPV?No21 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Awareness (Aim 1)Ever Heard of HPV?Yes81 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Awareness (Aim 1)Ever Heard of HPV Vaccine?No45 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Awareness (Aim 1)Ever Heard of HPV Vaccine?Yes57 Participants
Primary

Part 1: HPV Vaccine Behaviors 1 (Aim 1)

Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know.

Time frame: Day 1

Population: Missing data from 79 participants because orginal survey did not include this item, due to eligibility criteria at the time.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 1 (Aim 1)Yes0 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 1 (Aim 1)No17 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 1 (Aim 1)I Don't Know6 Participants
Primary

Part 1: HPV Vaccine Behaviors 2 (Aim 1)

Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know.

Time frame: Day 1

Population: Analysis is of vaccinated participants

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)1 Shot2 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)2 Shots1 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)3 Shots1 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)At Least 1 Shot, But I Don't Know How Many1 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)At Least 2 Shots, But I Don't Know How Many1 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Behaviors 2 (Aim 1)I Don't Know2 Participants
Primary

Part 1: HPV Vaccine Educational Preferences 1 (Aim 1)

A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Who would you like to receive information from?. Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied.

Time frame: Day 1

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Physicians96 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Other Healthcare Providers59 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Female Peer8 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Male Peer19 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Parent of Teen3 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Parent of Young Adult4 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)HPV Cancer Survivor40 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 1 (Aim 1)Other2 Participants
Primary

Part 1: HPV Vaccine Educational Preferences 2 (Aim 1)

Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, Best method for delivering education?. 1 being the best method and 8 being the worst method.

Time frame: Day 1

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website67 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person61 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person710 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform210 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person155 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person26 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person33 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person47 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person58 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)In Person812 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website113 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website226 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website318 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website414 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website59 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website78 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Website87 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App11 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App211 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App317 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App48 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App515 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App613 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App718 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Smart Phone App819 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar12 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar215 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar314 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar425 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar515 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar613 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar79 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Online Webinar89 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message16 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message210 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message313 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message412 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message511 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message614 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message719 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Text Message817 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet12 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet213 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet37 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet49 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet523 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet619 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet715 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Printed Booklet814 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform113 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform316 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform416 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform57 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform616 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform713 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Social Media Platform811 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal110 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal211 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal314 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal411 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal514 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal619 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal710 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 2 (Aim 1)Healthcare System Portal813 Participants
Primary

Part 1: HPV Vaccine Educational Preferences 3 (Aim 1)

An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, What age would it be most helpful to for a person to receive educational information?

Time frame: Day 1

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 30-45Check18 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 9-10Missing89 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 9-10Check13 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 11-14Missing74 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 11-14Check28 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 15-17Missing49 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 15-17Check53 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 18-22Missing50 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 18-22Check52 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 23-30Missing70 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 23-30Check32 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)Ages 30-45Missing84 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)I Do Not Think SoMissing102 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Educational Preferences 3 (Aim 1)I Do Not Think SoCheck0 Participants
Primary

Part 1: HPV Vaccine Health Beliefs 1 (Aim 1)

Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy.

Time frame: Day 1

ArmMeasureGroupValue (MEAN)Dispersion
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)Perceived Risk. 5 point scale with of Possible scale range 5-4022.81 score on a scaleStandard Deviation 10.93
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)What percentage of peers do you think have received the HPV vaccine? Possible scale Range 0-10020.01 score on a scaleStandard Deviation 22.78
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)What percentage of male peers do you think have received HPV vaccine? Possible scale Range 0-10016.26 score on a scaleStandard Deviation 20.03
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)What percentage of gay/bisexual males do you think have received HPV vaccine? Possible Range 1-10016.67 score on a scaleStandard Deviation 19.95
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)What percentage of female peers have received the HPV vaccine? Possible Scale Range 0-10024.71 score on a scaleStandard Deviation 26.62
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)What percentage of gay/bisexual females received the HPV vaccine? Possible Scale Range 0-10020.25 score on a scaleStandard Deviation 23.02
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)Perceived Norms. 8 items. Possible Score range 8-4026.55 score on a scaleStandard Deviation 8.65
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)Perceived Barriers. 3 items. Possible score range 3-15.7.19 score on a scaleStandard Deviation 3.01
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 1 (Aim 1)SELFEFF1 - SELFEFF9. 9 items. Possible Score range 9-45.17.75 score on a scaleStandard Deviation 7.05
Primary

Part 1: HPV Vaccine Health Beliefs 2 (Aim 1)

Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know.

Time frame: Day 1

Population: Participants in analysis are unvaccinated.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)Much below average27 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)Below average14 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)Average risk (Same risk as others your age)29 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)Above average6 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)Much above average5 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 2 (Aim 1)I don't know21 Participants
Primary

Part 1: HPV Vaccine Health Beliefs 3 (Aim 1)

Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions.

Time frame: Day 1

Population: Participants in analysis are unvaccinated.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineVery Unlikey15 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineSomewhat Unlikely2 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineA Little Unlikely5 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineNeither Unikely nor Likely13 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineA Little Likely5 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineSomewhat Likely26 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get information about the HPV vaccineVery Likely36 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,Very Unlikey14 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,Somewhat Unlikely5 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,A Little Unlikely5 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,Neither Unikely nor Likely27 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,A Little Likely8 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,Somewhat Likely31 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to obtain more than 1 shot in the next 12 months,Very Likely12 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureVery Unlikey12 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureSomewhat Unlikely9 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureA Little Unlikely4 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureNeither Unikely nor Likely20 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureA Little Likely2 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureSomewhat Likely24 Participants
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Health Beliefs 3 (Aim 1)Intention to get more than one dose in the futureVery Likely31 Participants
Primary

Part 1: HPV Vaccine Knowledge (Aim 1)

A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge.

Time frame: Day 1

Population: Unvaccinated participants only

ArmMeasureGroupValue (MEAN)Dispersion
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Knowledge (Aim 1)HPV Knowledge (Scale Score range 0-18)10.10 score on a scaleStandard Deviation 4.87
Aim 1 Only: Online Survey GroupPart 1: HPV Vaccine Knowledge (Aim 1)HPV Vaccination Knowledge Scale (Score range 0-9)3.19 score on a scaleStandard Deviation 2.56
Primary

Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2)

Number of participants who consented and participated in individual interviews.

Time frame: Day 1

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 2: Facilitators and Barriers to Intervention Implementation (Aim 2)20 Participants
Primary

Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3)

Number of Participants who completed either an individual interview or participated in a focus group.

Time frame: Day 1

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Aim 1 Only: Online Survey GroupPart 3: Feedback From Focus Groups or Individual Interviews (Aim 3)13 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026